MICAREO TAIWAN CO., LTD – Trademark Portfolio
Entity Type: 03
MICAREO TAIWAN CO., LTD holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include MICYTE, MICAREO, MISELECT, and SELECTCHIP. The owner is based in TAIPEI CITY.
5F., NO. 69, LN. 77,
XING'AI RD., NEIHU DIST.,
TAIPEI CITY 114 , TW
Showing of trademarks Trademarks
Trademark Classifications
MICAREO TAIWAN CO., LTD's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does MICAREO TAIWAN CO., LTD have?
MICAREO TAIWAN CO., LTD has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 cancelled.
What trademark classes does MICAREO TAIWAN CO., LTD file in?
MICAREO TAIWAN CO., LTD files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are MICAREO TAIWAN CO., LTD's most well-known trademarks?
MICAREO TAIWAN CO., LTD's registered trademark portfolio includes well-known marks such as MICYTE, MICAREO, MISELECT, and SELECTCHIP. These are among 4 currently registered trademarks in the portfolio.
What is MICAREO TAIWAN CO., LTD's trademark registration success rate?
MICAREO TAIWAN CO., LTD has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.